{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:11:38Z","timestamp":1781082698796,"version":"3.54.1"},"reference-count":22,"publisher":"Akademiai Kiado Zrt.","issue":"27","license":[{"start":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T00:00:00Z","timestamp":1656806400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2022,7,3]]},"abstract":"<jats:p>A Parsonage\u2013Turner-szindr\u00f3ma (PTS, plexitis brachialis) hirtelen fell\u00e9p\u0151,\n                    t\u00f6bbnyire egyoldali, s\u00falyos v\u00e1ll- vagy felkari f\u00e1jdalommal j\u00e1r\u00f3 neuritis. B\u00e1r a\n                    heves f\u00e1jdalom \u00e1ltal\u00e1ban \u00f6nkorl\u00e1toz\u00f3, a betegek k\u00e9tharmad\u00e1n\u00e1l az akut peri\u00f3dust\n                    a v\u00e1ll\u00f6v \u00e9s a proximalis fels\u0151 v\u00e9gtag izmait \u00e9rint\u0151 progressz\u00edv izomgyenges\u00e9g,\n                    reflexv\u00e1ltoz\u00e1sok, \u00e9rz\u00e9szavarok \u00e9s kr\u00f3nikus neuropathi\u00e1s f\u00e1jdalom k\u00f6veti. A\n                    PTS-eseteknek csak kis r\u00e9sze idiopathi\u00e1s, t\u00f6bbs\u00e9g\u00e9ben m\u0171t\u00e9tet, traum\u00e1t,\n                    fert\u0151z\u00e9st k\u00f6vet\u0151en vagy olt\u00e1si sz\u00f6v\u0151dm\u00e9nyk\u00e9nt sz\u00e1molnak be r\u00f3luk. Az ismert\n                    kiv\u00e1lt\u00f3 okok k\u00f6z\u00f6tt van a SARS-CoV-2-fert\u0151z\u00e9s, \u00e9s a k\u00fcl\u00f6nb\u00f6z\u0151 t\u00edpus\u00fa\n                    COVID\u201319-vakcin\u00e1ci\u00f3kat k\u00f6vet\u0151en is t\u00f6bbsz\u00f6r le\u00edrt\u00e1k m\u00e1r egyoldali PTS\n                    kialakul\u00e1s\u00e1t. A jelen k\u00f6zlem\u00e9nyben egy olyan esetet mutatunk be, amelyn\u00e9l a\n                    m\u00e1sodik Pfizer\u2013BioNTech BNT162b2 COVID\u201319-vakcina bead\u00e1s\u00e1t k\u00f6vet\u0151en 1 h\u00f3nappal\n                    jobb oldali, 7 h\u00f3nappal k\u00e9s\u0151bb pedig bal oldali r\u00e9szleges plexitis brachialis\n                    alakult ki. A PTS diagn\u00f3zis\u00e1t m\u00e1gnesesrezonancia- \u00e9s elektrodiagnosztikai\n                    vizsg\u00e1lat is meger\u0151s\u00edtette. A PTS el\u0151fordul\u00e1sa nem ritka, de az ismeretek\n                    hi\u00e1ny\u00e1ban kev\u00e9sszer gondolnak r\u00e1. K\u00f6zlem\u00e9ny\u00fcnk c\u00e9lja, hogy felh\u00edvjuk a figyelmet\n                    a PTS lehet\u0151s\u00e9g\u00e9re mind a SARS-CoV-2-fert\u0151z\u00e9s, mind a COVID\u201319-vakcin\u00e1ci\u00f3t\n                    k\u00f6vet\u0151en kialakult v\u00e1ll- vagy felkari f\u00e1jdalom eset\u00e9n, mert a korai felismer\u00e9s\n                    \u00e9s adekv\u00e1t kezel\u00e9s seg\u00edthet a betegs\u00e9g lefoly\u00e1s\u00e1nak r\u00f6vid\u00edt\u00e9s\u00e9ben. Orv Hetil.\n                    2022; 163(27): 1055\u20131060.<\/jats:p>","DOI":"10.1556\/650.2022.32546","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T11:37:48Z","timestamp":1656934668000},"page":"1055-1060","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":5,"title":["K\u00e9toldali Parsonage\u2013Turner-szindr\u00f3ma COVID\u201319-vakcin\u00e1ci\u00f3t k\u00f6vet\u0151en."],"prefix":"10.1556","volume":"163","author":[{"given":"Krisztina","family":"Luk\u00e1cs","sequence":"first","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Belgy\u00f3gy\u00e1szati \u00e9s Hematol\u00f3giai Klinika Budapest, Szentkir\u00e1lyi u. 46., 1088 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Cs\u0151regh","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Belgy\u00f3gy\u00e1szati \u00e9s Hematol\u00f3giai Klinika Budapest, Szentkir\u00e1lyi u. 46., 1088 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Fekete","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Belgy\u00f3gy\u00e1szati \u00e9s Hematol\u00f3giai Klinika Budapest, Szentkir\u00e1lyi u. 46., 1088 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1 Beatty AL, Peyser ND, Butcher XE, et al. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open 2021; 4: e2140364.","DOI":"10.1001\/jamanetworkopen.2021.40364"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"2 Baden","year":"2021","unstructured":"2 Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021; 384: 403-416.","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"3 Polack","year":"2020","unstructured":"3 Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020; 383: 2603-2615.","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"S vaccine against Covid-19","volume":"384","author":"4 Sadoff","year":"2021","unstructured":"4 Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021; 384: 2187-2201.","journal-title":"N Engl J Med"},{"issue":"6513","key":"ref4","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0140-6736(48)90611-4","article-title":"Neuralgic amyotrophy; the shoulder-girdle syndrome","volume":"1","author":"Parsonage MJ","year":"1948","unstructured":"5 Parsonage MJ, Turner JW. Neuralgic amyotrophy; the shoulder-girdle syndrome. Lancet 1948; 1(6513): 973-978.","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/ng1649","article-title":"Mutations in SEPT9 cause hereditary neuralgic amyotrophy","volume":"37","author":"6 Kuhlenb\u00e4umer","year":"2005","unstructured":"6 Kuhlenb\u00e4umer G, Hannibal MC, Nelis E, et al. Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat Genet. 2005; 37: 1044-1046.","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/mus.25008","article-title":"Neuralgic amyotrophy: an update on diagnosis, pathophysiology, and treatment","volume":"53","author":"7 Van Eijk","year":"2016","unstructured":"7 Van Eijk JJ, Groothuis JT, Van Alfen N. Neuralgic amyotrophy: an update on diagnosis, pathophysiology, and treatment. Muscle Nerve 2016; 53: 337-350.","journal-title":"Muscle Nerve"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clinimag.2020.11.017","article-title":"Parsonage-Turner syndrome associated with SARS-CoV2 (COVID-19) infection","volume":"72","author":"8 Mitry","year":"2021","unstructured":"8 Mitry MA, Collins LK, Kazam JJ, et al. Parsonage-Turner syndrome associated with SARS-CoV2 (COVID-19) infection. Clin Imaging 2021; 72: 8-10.","journal-title":"Clin Imaging"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9 Cacciavillani M, Salvalaggio A, Briani C. Pure sensory neuralgic amyotrophy in COVID-19 infection. Muscle Nerve 2021; 63: E7-E8.","DOI":"10.1002\/mus.27083"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10 Coffman JR, Randolph AC, Somerson JS. Parsonage-Turner syndrome after SARS-CoV-2 BNT162b2 vaccine: a case report. JBJS Case Connect. 2021; 11(3): e21.00370.","DOI":"10.2106\/JBJS.CC.21.00370"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11 Mahajan S, Zhang F, Mahajan A, et al. Parsonage-Turner syndrome after COVID-19 vaccination. Muscle Nerve 2021; 64: E3-E4.","DOI":"10.1002\/mus.27255"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12 Flikkema KD, Brossy KD. Parsonage-Turner syndrome after COVID-19 vaccination: a case report. JBJS Case Connect. 2021; 11(4): e2100577.","DOI":"10.2106\/JBJS.CC.21.00577"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1148\/radiol.2021211374","article-title":"Parsonage-Turner syndrome following COVID-19 vaccination: MR neurography","volume":"302","author":"13 Queler","year":"2022","unstructured":"13 Queler SC, Towbin AJ, Milani C, et al. Parsonage-Turner syndrome following COVID-19 vaccination: MR neurography. Radiology 2022; 302: 84-87.","journal-title":"Radiology"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14 Diaz-Segarra N, Edmond A, Gilbert C, et al. Painless idiopathic neuralgic amyotrophy after COVID-19 vaccination: a case report. PM R 2021 Apr 22. . [Epub ahead of print]","DOI":"10.1002\/pmrj.12619"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15 Sharma A, Gupta A. A rare case of brachial plexus neuropraxia after COVID-19 vaccination. Cureus 2022; 14: e21244.","DOI":"10.7759\/cureus.21244"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1186\/s13256-021-03176-8","article-title":"Parsonage-Turner syndrome following coronavirus disease 2019 immunization with ChAdOx1-S vaccine: a case report and review of the literature","volume":"15","author":"16 Vitturi","year":"2021","unstructured":"16 Vitturi BK, Grandis M, Beltramini S, et al. Parsonage-Turner syndrome following coronavirus disease 2019 immunization with ChAdOx1-S vaccine: a case report and review of the literature. J Med Case Rep. 2021; 15: 589.","journal-title":"J Med Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.nrl.2021.05.007","article-title":"Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine","volume":"36","author":"17 Crespo Burillo","year":"2021","unstructured":"17 Crespo Burillo JA, Loriente Mart\u00ednez C, Garc\u00eda Arguedas C, et al. Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine. Neurologia (Engl Ed). 2021; 36: 571-572.","journal-title":"Neurologia (Engl Ed)"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18 Siepmann T, Kitzler HH, Lueck C, et al. Neuralgic amyotrophy following infection with SARS-CoV-2. Muscle Nerve 2020; 62: E68-E70.","DOI":"10.1002\/mus.27035"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11420-010-9176-x","article-title":"Parsonage-Turner syndrome","volume":"6","author":"Feinberg JH","year":"2010","unstructured":"19 Feinberg JH, Radecki J. Parsonage-Turner syndrome. HSS J. 2010; 6: 199-205.","journal-title":"HSS J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/brain\/awh722","article-title":"The clinical spectrum of neuralgic amyotrophy in 246 cases","volume":"129","author":"van Alfen N","year":"2006","unstructured":"20 van Alfen N, van Engelen BG. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain 2006; 129: 438-450.","journal-title":"Brain"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.molmed.2017.01.006","article-title":"Type I interferons modulate CD8(+) T cell immunity to mRNA vaccines","volume":"23","author":"Beuckelaer A","year":"2017","unstructured":"21 De Beuckelaer A, Grooten J, De Koker S. Type I interferons modulate CD8(+) T cell immunity to mRNA vaccines. Trends Mol Med. 2017; 23: 216-226.","journal-title":"Trends Mol Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1056\/NEJMoa2116185","article-title":"Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico","volume":"386","author":"22 Dunkle","year":"2022","unstructured":"22 Dunkle LM, Kotloff KL, Gay CL, et al. Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico. N Engl J Med. 2022; 386: 531-543.","journal-title":"N Engl J Med"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/163\/27\/article-p1055.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/163\/27\/article-p1055.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/163\/27\/article-p1055.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T08:23:53Z","timestamp":1698308633000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/163\/27\/article-p1055.xml"}},"subtitle":["Esetismertet\u00e9s \u00e9s az irodalom \u00e1ttekint\u00e9se"],"short-title":[],"issued":{"date-parts":[[2022,7,3]]},"references-count":22,"journal-issue":{"issue":"27"},"URL":"https:\/\/doi.org\/10.1556\/650.2022.32546","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,3]]}}}